Concepedia

William H. Doub

WH

Statistics

Publications

38

Citations

1.9K

H-Index

24

Active since

1973

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Merck & Co., Inc., Rahway, NJ, USA (United States)

Boehringer Ingelheim (United States)

RTI International

William H. Doub is an author at United States Food and Drug Administration specializing in pharmacy, pharmaceutics, and bioavailability.

ORCID

Publications per year

1973–2023

38

Publications

38

Lack of Significant Dermal Penetration of Titanium Dioxide from Sunscreen Formulations Containing Nano- and Submicron-Size TiO2 Particles

Nakissa Sadrieh, Anna M. Wokovich, Neera V. Gopee et al. · Toxicological Sciences · 2010 · 303 citations · Full text

, , +15

Electrochemical reduction of sulfur in aprotic solvents

Robert P. Martin, William H. Doub, Julian L. Roberts et al. · Inorganic Chemistry · 1973 · 147 citations

, , +5

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Vinod P. Shah, Kamal K. Midha, Shrikant V. Dighe et al. · International Journal of Pharmaceutics · 1992 · 132 citations

, , +14

Comparing Methods for Detecting and Characterizing Metal Oxide Nanoparticles in Unmodified Commercial Sunscreens

Katherine M. Tyner, Anna M. Wokovich, William H. Doub et al. · Nanomedicine · 2009 · 128 citations

, , +17

Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Jayne E. Hastedt, Per Bäckman, Andrew Clark et al. · AAPS Open · 2016 · 110 citations · Full text

, , +17

1–5 of 38